Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
3.01B | 3.05B | 3.07B | 2.45B | 1.51B | 686.31M | Gross Profit |
1.23B | 1.96B | 570.60M | 1.58B | 997.60M | 450.85M | EBIT |
324.20M | 359.30M | 371.80M | 91.80M | -230.04M | -590.82M | EBITDA |
566.20M | 616.30M | 603.90M | 140.90M | -3.79M | -511.73M | Net Income Common Stockholders |
246.00M | 309.70M | 188.20M | -268.00M | -422.21M | -617.95M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
699.40M | 1.06B | 849.10M | 674.50M | 707.34M | 655.34M | Total Assets |
4.68B | 5.07B | 4.84B | 4.82B | 5.23B | 5.56B | Total Debt |
3.46B | 3.46B | 3.55B | 3.78B | 3.94B | 3.93B | Net Debt |
2.77B | 2.40B | 2.70B | 3.10B | 3.24B | 3.28B | Total Liabilities |
4.32B | 4.46B | 4.52B | 4.70B | 4.90B | 4.76B | Stockholders Equity |
349.20M | 594.40M | 309.80M | 110.20M | 322.90M | 787.97M |
Cash Flow | Free Cash Flow | ||||
220.20M | 315.20M | 294.80M | 25.30M | 70.68M | -414.03M | Operating Cash Flow |
369.60M | 466.00M | 444.30M | 136.00M | 166.22M | -330.10M | Investing Cash Flow |
-138.90M | -146.90M | -131.80M | -96.30M | -89.30M | -83.37M | Financing Cash Flow |
-322.80M | -103.10M | -125.40M | -52.20M | -19.93M | 584.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $3.73B | 21.43 | 71.46% | 0.25% | -0.80% | 13.07% | |
70 Outperform | $1.45B | 58.21 | 9.00% | ― | -1.98% | -1.18% | |
66 Neutral | $522.02M | ― | -2.83% | 1.64% | 4.18% | -207.46% | |
60 Neutral | $14.12B | 6.43 | -3.56% | 3.69% | 2.49% | -35.43% | |
55 Neutral | $1.40B | ― | 20.03% | ― | -5.43% | 26.07% |
On May 15, 2025, Cinemark Holdings held its Annual Meeting of Stockholders, where key decisions were made regarding the company’s governance and financial oversight. The stockholders elected nominees to the Board of Directors to serve until 2028, approved the 2024 compensation for the company’s Named Executive Officers, and ratified the selection of Deloitte & Touche LLP as the independent public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (CNK) stock is a Buy with a $34.00 price target. To see the full list of analyst forecasts on Cinemark Holdings stock, see the CNK Stock Forecast page.
On May 15, 2025, Cinemark Holdings, Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, to be paid on June 12, 2025, to stockholders of record as of May 29, 2025. This announcement underscores Cinemark’s commitment to returning value to its shareholders and may positively impact investor sentiment, reflecting the company’s stable financial position and confidence in its ongoing operations.
The most recent analyst rating on (CNK) stock is a Buy with a $34.00 price target. To see the full list of analyst forecasts on Cinemark Holdings stock, see the CNK Stock Forecast page.
On May 2, 2025, Cinemark Holdings announced its financial results for the first quarter of 2025, reporting a total revenue of $541 million and a net loss of $39 million. Despite a challenging box office environment due to the lingering effects of the 2023 Hollywood strikes, Cinemark exceeded industry benchmarks both domestically and internationally. The company is optimistic about the industry’s recovery trajectory, with strong consumer enthusiasm for theatrical experiences. Cinemark also paid its first dividend since the pandemic and initiated a $200 million stock buyback program to manage potential dilution from convertible notes. The company entertained 37 million moviegoers globally and achieved significant market share growth in the U.S. and Latin America.
On February 28, 2025, Cinemark Holdings entered into a new employment agreement with Ms. Wanda Gierhart, who has been with the company since 2018 in various marketing leadership roles. The agreement outlines her compensation, including a base salary of $575,000, eligibility for bonuses, and participation in the company’s equity incentive plan. The contract also details severance packages and benefits in the event of termination, ensuring Ms. Gierhart’s continued contribution to the company’s marketing strategies and operations.